Product Portfolio

MediPharm delivers a targeted portfolio of sterile injectables and infusion therapies designed for hospital and clinical use across gastroenterology, oncology, infectious disease, cardiovascular care, and bone metabolism. Our portfolio combines proven, essential medicines with specialty lyophilized formulations developed for stability, rapid bedside preparation, and consistent clinical performance.

Key product groups

Infusion solutions for gastroenterology and hepatology

ready‑to‑use and concentrate formats for IV administration.

Lyophilized powders for reconstitution

antiviral and other specialty sterile powders engineered for stability and rapid preparation.

Injectable oncology support and bone‑metabolism agents

cytoprotective and antiresorptive therapies supplied in flexible dose formats.

Critical‑care injectables and antidotes

products designed for perioperative and emergency use with strict quality and traceability controls.

Product examples
Omeprazole

40 mg Lyophilized Powder for Injection

A lyophilized formulation designed for intravenous administration. Omeprazole is used for rapid acid suppression in conditions such as peptic ulcers, gastroesophageal reflux disease (GERD), and stress-induced mucosal injury in critically ill patients. The lyophilized form ensures stability and ease of reconstitution for immediate use in clinical settings.

Protamine Sulfate

Injection 50 mg/5 ml

A critical antidote designed to neutralize the anticoagulant effects of heparin during and after surgical procedures. This formulation enables precise dosing and prompt reversal of heparin’s effects, thereby minimizing bleeding risks and enhancing patient safety in peri-operative settings.

Nimodipine

Injection 50 ml/10 mg

Specifically formulated for neurovascular care, Nimodipine is a calcium channel blocker used primarily for reducing the risk of cerebral vasospasm in patients suffering from subarachnoid hemorrhage. Its infusion formulation ensures controlled delivery to improve cerebral blood flow and enhance neurological outcomes.

Calcium Folinate

Injection 10 mg/ml

This product, commonly known as leucovorin, is used in oncology as a “rescue” agent from the toxic effects of high-dose methotrexate therapy. Administered at 10 mg/ml, it replenishes folinic acid levels, thereby reducing side effects and allowing continued effective chemotherapy.

Acyclovir

Powder for Infusion

A critical antiviral medication presented as a lyophilized powder for infusion solution. After reconstitution, Aciclovir is used to treat severe herpes simplex infections, varicella zoster, and other viral infections in immunocompromised patients. Its formulation allows for rapid preparation and administration, ensuring timely therapeutic action against viral replication by inhibiting viral DNA polymerase.

Pamidronate Disodium

Injection Solution

Available in multiple dosage variants (30 mg, 60 mg, and 90 mg), this bisphosphonate is used to treat conditions involving enhanced bone resorption, such as Paget’s disease, osteolytic lesions, and hypercalcemia. The flexible dosing options allow clinicians to tailor therapy to the severity of a patient’s condition while maintaining a high margin of safety.

Zoledronic Acid

Injection Concentrate for Infusion (4 mg/5 ml)

A bisphosphonate agent formulated as a concentrated solution for infusion. It is indicated for managing malignant bone disease, hypercalcemia of malignancy, and various metabolic bone disorders. The concentration is optimized for safe and efficient administration, inhibiting osteoclast-mediated bone resorption and reducing skeletal-related events.

Why hospitals and partners choose MediPharm

Proven aseptic and lyophilization expertise with EU‑GMP manufacturing standards.

Portfolio focused on high‑reliability hospital needs and clinical trial supply.

Flexible batch sizes (pilot to commercial) and tailored packaging options.

Strong regulatory and quality track record with recent successful GMP audits.

Contact us

MediPharm a.s.

Contact our CDMO team
Request product development dossier

Addres:
kpt. Nálepku 637/2, 082 71,
Lipany, Slovak republic.

Phone: +421 51/4880 222

Email: info@medi-pharm.sk